| Old Articles: <Older 45521-45530 Newer> |
|---|
 |
The Motley Fool
November 19, 2010
Brian Orelli |
Up 95%, but Still Risky as Heck That's an understatement for MELA Sciences.   |
The Motley Fool
November 19, 2010
Andrew Bond |
A Tech Stock Value Masters Could Love Look past traditional valuation methods to find value. |
The Motley Fool
November 19, 2010
Christopher Barker |
Surprise-Seekers Must Love DryShips DryShips CEO "Curious" George Economou is full of surprises. Surprise: DryShips generated more revenue from its ultra-deepwater drillships than it did from its dry bulk segment. |
The Motley Fool
November 19, 2010
Anders Bylund |
Where Will Blue Coat Turn Next? With fresh thinking at the top and an impressive stable of marketing partners, Blue Coat is poised for big things. |
The Motley Fool
November 19, 2010
David Lee Smith |
BHP's Moved on, But Vale's Expanding in Canada While Canada has shut out BHP's acquisition, Brazil's Vale has big plans up there. |
The Motley Fool
November 19, 2010
Rich Smith |
Can Nothing Stop Salesforce? No, nothing can. (Until something does.) |
The Motley Fool
November 19, 2010
Brian Orelli |
How to Get Rich Buying This Trend As the baby boomers get older, the number of medical procedures and drugs that the average American takes will increase. |
The Motley Fool
November 19, 2010
Esterhuizen & Sellitti |
CAPS Favorites: Which Side of the China Trade Are You On? Are you bullish or bearish on China? |
The Motley Fool
November 19, 2010
Jacob Roche |
All Hail the Amazing American Consumer! Buying luxury with aplomb -- while pinching every penny! Sales were up at both deep discounter Dollar Tree and luxury retailer Williams-Sonoma. |
The Motley Fool
November 19, 2010
Brian Orelli |
One Drug, Two Names, Two Wildly Different Prospects Amgen double speaks for increased sales. |
| <Older 45521-45530 Newer> Return to current articles. |
